New Delhi, March 23 (IANS) Missing cases of Tuberculosis (TB) coupled with diagnostic and treatment delays are the major roadblocks in India’s mission to end the deadly infection in the country by 2025, said Dr. Kuldeep Singh Sachdeva, the former head of India’s TB elimination programme at the Ministry of Health and Family Welfare (as Deputy Director General – TB) on Saturday.
According to the latest global research published in The Lancet Infectious Diseases journal, ahead of World Tuberculosis Day on March 24, tuberculosis incidence in India dropped only marginally by 0.5 per cent between 2015 and 2020.
The study reported that in 2020 India’s TB incidence stood at 213 cases per one lakh population, while deaths were between 3.5-5 lakh — both remain well above the targets.
“Missing TB cases remain an important source of continued TB transmission. Ending TB is not possible without reaching all cases in the community, diagnosing them early and treating and supporting them towards a cure,” Dr. Kuldeep, currently the President and Chief Medical Officer of Goa-based Molbio Diagnostics, told IANS.
Raising public awareness and health-seeking behaviour followed by screening with sensitive tools like ultraportable X-rays, which can be deployed closer to them, are some of the ways to reach such cases, said the public health expert.
“Those who screen positive would need a final confirmation with highly sensitive and specific molecular tests preferably point of care tests as they can be deployed closer to patients even in remote settings. Deployment closer to the cases can save out-of-pocket expenses of the community and does not interrupt the routine day-to-day workflow of the cases and caregivers,” he noted.
Dr. Kuldeep also pointed out the delay between diagnosis and treatment that is increasing the spread of the deadly disease.
“Diagnostic and treatment delays are still being observed. These delays imply continued transmission of infective pools, potential for advanced disease and poor outcomes.
“Universal screening and deployment of point of care rapid diagnostics has the potential to diagnose cases early in the disease process. This coupled with starting treatment within 24-48 hours of diagnosis can interrupt the chain of transmission effectively,” he explained.
Rapid molecular diagnostic tests must be the initial diagnostic test in all persons with signs and symptoms of TB, as per the World Health Organization (WHO) guideline.
While there has been some progress in the use of molecular tests in India, the country “is still to reach its optimal potential,” the expert said.
Even as India aims to achieve the target of eliminating TB by 2025, in 2022, the country accounted for the highest number of TB cases in the world, as per the WHO’s 2023 report. With a whopping 2.8 million TB cases, India “represented 27 per cent of the global burden”.
“India is committed to achieving sustainable development goals for TB by 2025,” Dr. Kuldeep said.
“The country has taken various new initiatives to achieve rapid decline in cases quickly and implementation seems to be on track. The current burden remains high and these efforts need to be sustained for a few years to achieve SDGs,” he added.
(Rachel V. Thomas can be contacted at rachel.t@ians.in)
–IANS
rvt/dan
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
